ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells
about
The epithelial-mesenchymal transition (EMT) phenomenonRaf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7Cancer Stem Cell Plasticity Drives Therapeutic ResistancePITPNC1 Recruits RAB1B to the Golgi Network to Drive Malignant SecretionmiR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasisCoupled reversible and irreversible bistable switches underlying TGFβ-induced epithelial to mesenchymal transitionCPEB2-eEF2 interaction impedes HIF-1α RNA translationMetastatic behaviour of primary human tumours in a zebrafish xenotransplantation modelThe relationship between terminal functionalization and molecular weight of a gene delivery polymer and transfection efficacy in mammary epithelial 2-D cultures and 3-D organotypic culturesInduction of epithelial mesenchimal transition and vasculogenesis in the lenses of Dbl oncogene transgenic mice.The tale of transforming growth factor-beta (TGFbeta) signaling: a soigné enigma.TGF-beta-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEIImmune promotion of epithelial-mesenchymal transition and generation of breast cancer stem cells.ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progressionHeterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: Focus on hnRNP E1's multifunctional regulatory roles.The FAM3 superfamily member ILEI ameliorates Alzheimer's disease-like pathology by destabilizing the penultimate amyloid-β precursor.Enhanced glucose tolerance in pancreatic-derived factor (PANDER) knockout C57BL/6 mice.Establishment of a TGFβ-induced post-transcriptional EMT gene signature.Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancerIdentification of an mRNP complex regulating tumorigenesis at the translational elongation stepStopped in translation: EMT control meets eukaryotic elongationUse of conventional and -omics based methods for health claims of dietary antioxidants: a critical overview.BI 5700, a Selective Chemical Inhibitor of IκB Kinase 2, Specifically Suppresses Epithelial-Mesenchymal Transition and Metastasis in Mouse Models of Tumor Progression.Interleukin-like epithelial-to-mesenchymal transition inducer activity is controlled by proteolytic processing and plasminogen-urokinase plasminogen activator receptor system-regulated secretion during breast cancer progression3'-UTR-mediated post-transcriptional regulation of cancer metastasis: beginning at the end.Annexin A1 attenuates EMT and metastatic potential in breast cancer.CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinoma.Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells.Prognostic significance of FAM3C in esophageal squamous cell carcinoma.Semaphorin-7a reverses the ERF-induced inhibition of EMT in Ras-dependent mouse mammary epithelial cellsAF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis.Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell linesTransforming Growth Factor-β1 Induced Epithelial Mesenchymal Transition is blocked by a chemical antagonist of translation factor eIF4EIn-depth proteomic analysis of nonsmall cell lung cancer to discover molecular targets and candidate biomarkers.Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathwayHes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway.Fam3c modulates osteogenic cell differentiation and affects bone volume and cortical bone mineral densityTumor immunoediting and immunosculpting pathways to cancer progression.A follow-up association study of two genetic variants for bone mineral density variation in Caucasians.Breast cancer stem cells, pathways and therapeutic perspectives 2011.
P2860
Q24600898-FAD11A50-939E-4E7E-9A92-3F093E33FB33Q24649908-1365F1DA-D404-4CB7-AD1A-DEABAB2CB877Q26770274-2C995803-76A0-4969-9890-7C1CA7897536Q28118950-BDAB9956-87E6-4F32-8FC0-DBBC3FBAF784Q28236600-730DF996-1F9D-44CE-858C-9AFA8F27059AQ28297232-85635862-4CF9-44F1-8C27-7BE0CE7374D4Q28509318-3FDBB2ED-5400-45E2-A67F-25AE1F2C2D8BQ30488255-BE9E2A9C-5190-40E0-84D0-B1CD8DBB6ECAQ30504481-622AE068-6BD9-49E4-A3DA-C0CA04BC8644Q30873811-75BFB8D3-FE6D-474A-B50F-F12E4AD12B36Q33607396-D3CDFD4C-D6BB-48E2-B394-80CF2B53B3FFQ33696388-459EE3FA-A778-44E3-B8E8-F7F6560C9B63Q33795345-F875EBF1-2BCC-448B-8590-C94D58D0795AQ33977419-C1424324-FD67-4611-B050-671CDA564F7CQ34002192-B3ACFF7C-4FBB-4F05-9968-BDB8BD90421CQ34422762-62F74982-AFD9-4476-8B1B-12A125D539B3Q34424190-E69CDCB3-12D3-48EF-A137-AE118C98B4FFQ34534249-F9898EE0-70E1-436B-A807-F370C1D8A32CQ34570526-7C081E90-8E70-4C6D-BABC-759F13E571E4Q34701472-87D7B04A-D818-4B7A-A146-0FF08AE3D0F0Q34746251-93665A74-5E2A-4B62-8C69-29BFF8BC1DB0Q34781792-94FAFAFC-94F8-4625-9B73-1CB79F6C4ACFQ34972203-48DB88E6-D433-47FF-AC0B-BCCBD4EBF21AQ34999819-F787E47E-DFA9-4861-807D-5DA1F3BE63E8Q35987603-2E5B4BE6-06E6-4A84-BFFD-6D8C1B4524D7Q36039344-1F8801D6-B831-4EE7-BF0A-E49363EB029BQ36067765-5D389711-6125-4D77-8899-241E24FB4447Q36142170-AC341EB4-937A-48BF-A2FA-15C85F3B0CF3Q36203190-C22F3890-47BB-4886-9888-448FC1150DC2Q36284517-C2300A77-10C3-455A-AEBA-F69BAE6429BFQ36299786-CD11A064-395B-45FB-BEF1-13D07CA37512Q36381496-1CE17E8E-E5CD-4A7D-8F95-01761B13F9EAQ36382304-4A3D0811-1FB0-4A7A-8758-E9E8BE7EA422Q36386730-72C97648-5BBC-4921-987A-B17DCFEE057BQ36513525-41FBEFF8-6DF9-4668-A29B-72E9A25AAAA0Q36546768-C76D91E5-6688-45C7-9B48-06CEF841A7E3Q36769635-97A7E392-1F03-41F7-A32C-117ED3947783Q36896195-642F67BA-D320-4A52-9DE8-D99459508F2CQ36928755-7FEAC81C-1ACF-45EE-B3AC-6DBC6A2A855CQ36946326-7D7AB54B-6010-41A2-BE8C-8B9C668B39BC
P2860
ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
ILEI: a cytokine essential for ...... metastasis in epithelial cells
@ast
ILEI: a cytokine essential for ...... metastasis in epithelial cells
@en
ILEI: a cytokine essential for ...... metastasis in epithelial cells
@nl
type
label
ILEI: a cytokine essential for ...... metastasis in epithelial cells
@ast
ILEI: a cytokine essential for ...... metastasis in epithelial cells
@en
ILEI: a cytokine essential for ...... metastasis in epithelial cells
@nl
prefLabel
ILEI: a cytokine essential for ...... metastasis in epithelial cells
@ast
ILEI: a cytokine essential for ...... metastasis in epithelial cells
@en
ILEI: a cytokine essential for ...... metastasis in epithelial cells
@nl
P2093
P1433
P1476
ILEI: a cytokine essential for ...... metastasis in epithelial cells
@en
P2093
Annamaria Gal
Hartmut Beug
Memetcan Alacakaptan
Rupert Oberauer
Thomas Brabletz
Thomas Waerner
P304
P356
10.1016/J.CCR.2006.07.020
P407
P577
2006-09-01T00:00:00Z